06 December 2023: Articles
Unusual Presentation of Lumbar Surgical Site Infection: A Case Study of Early Onset Infection after Arthrodesis
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
Chloé Ducrocq1EF, François Luc2ABCDEFG*, Abdeljalil Zeggay3E, Martin Petit1F, Mourad Ould-Slimane1AEFDOI: 10.12659/AJCR.941844
Am J Case Rep 2023; 24:e941844
Abstract
BACKGROUND: Infection is a serious surgical complication that significantly increases morbidity rates and health care expenses. Most human Pasteurella multocida infections are soft-tissue infections caused by dog or cat bites. Pasteurella multocida (P. multocida) is present in the oral, nasopharyngeal, and upper respiratory tract microbiota among cats, dogs, and other domestic or wild animals. Here, we report a case of lumbar surgical site infection caused by this bacterium.
CASE REPORT: A 70-year-old diabetic and overweight woman had a Pasteurella multocida surgical site infection after lumbar arthrodesis carried out for lumbar stenosis associated with spondylolisthesis. The patient had been in contact with her cat and claimed to have simply slept with it in her bed. Multiple antibiotic therapies and 3 debridement-irrigations with change of spinal implants during the last revision were needed.
CONCLUSIONS: Infections caused by P. multocida are rare and most often occur as a result of animal scratches or bites, but can sometimes occur after simple contact with an animal. Surgical site infection of spinal arthrodesis due to Pasteurella multocida implies treatment difficulties. In case of Pasteurella multocida infection of lumbar spinal arthrodesis, even in the early period, implant removal seems to be useful to limit the appearance of biofilm more specific to this micro-organism.
Keywords: case reports, Neurosurgery, Orthopedic Procedures, Pasteurella multocida, Aged, Animals, Female, Humans, Anti-Bacterial Agents, Bites and Stings, Pasteurella Infections, Spinal Fusion, Surgical Wound Infection, Cats
Background
Instrumented spinal fusion surgery is associated with a significant rate of surgical site infection (1–12%) [1,2]. The most frequently found pathogens are
Case report
Our patient was a 70-year-old woman who was overweight (body mass index (BMI)=29 kg/m2) and was an active smoker (22 pack-years) and had diabetes mellitus, peripheral arterial disease, and high blood pressure was suffering from neurogenic claudication associated with fifth lumbar vertebrae (L5) radicular pain. Magnetic resonance imaging (MRI) and computed tomography (CT) scan show a 3-level lumbar stenosis associated with degenerative third lumbar vertebrae-fourth lumbar vertebrae (L3–L4) spondylolisthesis (Figure 1). After a well-conducted medical treatment, lumbar decompression and arthrodesis were performed.
Postoperative radiographs were satisfying (Figure 2). The postoperative course was simple, the patient remained apyretic, and her scar was clean. She was discharged from the hospital 6 days (D6) after surgery. Eight days later (D14), she came to the Emergency Department with scar exudate, without fever.
Blood analysis showed biological inflammatory syndrome (Figure 3). We performed debridement and irrigation with antiseptic serum using a pulsed lavage system (Figure 4).
After taking intraoperative bacteriological samples, we initiated empirical antimicrobial therapy with daptomycin 10 mg/kg/d and piperacillin-tazobactam 4 g/6 h in accordance with local protocol. We used postoperative external drainage for 3 days. Microbiological cultures only identified
Five days after revision surgery (D19), we adapted antimicrobial therapy according to a multidisciplinary meeting, including infectious disease specialists. We started high-dose intravenous amoxicillin-clavulanate 2 g/4 h. We preferred amoxicillin-clavulanate to amoxicillin alone to cover other potential pathogens while waiting for the final microbiological results. Indeed, we wanted to maintain protection against gram-negative bacteria and anaerobic coverage while we tried to understand the mode of contamination.
Two days later (D21), a new purulent exudate occurred from the scar without fever nor pain but with a slight biological inflammatory syndrome (Figure 3). We performed a new debridement-irrigation associated with new intraoperative bacteriological sampling. We extended antibiotic therapy by discontinuing amoxicillin-clavulanate and replaced it with intravenous daptomycin and piperacillin-tazobactam at the same dosages as initially prescribed.
Seven days after the second debridement-irrigation (D28), the clinical and biological evolution was satisfying (Figure 3) and allowed us to discontinue daptomycin and introduce per os levofloxacin 750 mg/d in combination with intravenous amoxicillin-clavulanate.
On the next day (D29), an abundant and purulent scar flow appeared again. Following the advice of infectious disease specialists, we stopped antibiotics to be able to obtain a microbiological sample without antimicrobial treatment exposure. We performed new sampling, debridement, and irrigation. A local instillation of vancomycin powder (2 g) was added. We also removed and refitted the arthrodesis implants, and we introduced postoperative intravenous antimicrobial therapy with meropenem 2 g/8 h and daptomycin 10 mg/kg/d.
Four days after this third revision procedure (D33), in the absence of new microbiological identification, we switched antimicrobial treatment to daptomycin 10 mg/kg/d and ceftriaxone 1 g/12 h. The delayed cultures were negative but Pasteurella was detected at D39 in polymerase chain reaction (PCR) amplification of 16S rDNA genes. The clinical and biological evolution was then satisfying (Figure 3), allowing us to discontinue daptomycin and continue ceftriaxone alone. Eleven days after the third surgical revision (D40), the good outcomes allowed us to stop the ceftriaxone and to introduce per os doxycycline 100 mg twice a day, which has better tolerance and spectrum than levofloxacin. The multiple changes in antibiotic therapy were due to the fact that we suspected superinfection by another pathogen. We then proceeded to early rehabilitation as soon as the results of the first cultures did not reveal new microbiological documentation.
The treatment was conducted during 12 weeks from the last debridement-irrigation, with a good tolerance. The biological inflammatory syndrome had disappeared during that time, and the scar remained clean. The patient had a good clinical and radiological (Figure 7) outcome without lumbar neither radicular pain at the last follow-up (12 months).
Discussion
In our case, a complete change of equipment as soon as the pathogen was identified, combined with lavage and effective antibiotic therapy, would appear to be the only solution for definitively curing this infection. Animal bites, scratches, or licks from pets are possible in people who have undergone spinal surgery requiring equipment, and we believe that they should be informed about the risks and measures to take in case of a bite. Its implication in spinal surgical site infection appears exceptional. This case illustrates the difficulties of treatment, which required 3 debridement-irrigations. Superficial infections of the surgical site are very rare in the presence of lumbar scar discharge and should not be a diagnostic option delaying deep surgical debridement, which must include deep soft tissue and bone, as well as implants. The unusual failure of this recurring strategy made us suspect
Septic complications are a significant concern among the potential risks associated with spine surgery. The occurrence of acute surgical site infections in this domain surpasses that observed in other orthopaedic surgeries and these infections may result in more severe local and general complications. As such, special attention must be given to the prevention and management of septic complications in patients undergoing spine surgery.
The rate of this adverse event reported in the literature is between 0.5% and 20% [7]. The observed variability can be attributed to the extensive diversity of surgical interventions and the patient population undergoing surgery [8].
Postoperative infections are predominantly linked to gram-positive cocci, with
The identification of pathogens can be affected by the specific anatomical location of the surgical procedure. It has been noted that digestive contaminations are commonly observed in the lumbar spine and lumbosacral region [9–13].
A multidisciplinary coordination meeting should be organized to encourage collaboration and deliberate on the most effective therapeutic approach. For early-onset spinal implant infection, debridement surgery with implant retention followed by combination antibiotic therapy for 3 months classically appeared safe and effective [14–16].
Indeed, according to international recommendations, there is little information available on management of spinal implant infection. Indications and modalities of surgical treatment are relatively well defined: implants should be removed whenever spinal fusion is achieved [7,17,18]. If the removal of an implant is hazardous, as in early-onset spinal implant infections, debridement surgery with implant retention should be performed [19].
When the implant cannot be removed, the modalities of antibiotic treatment are crucial to prevent a relapse of the infection.
At our institution, all patients with postoperative spinal implant infections are treated by an interdisciplinary team including surgeons, infectious disease specialists, and microbiologists.
In this case, antibiotic therapy with daptomycin and piperacillin-tazobactam was initiated in light of the local bacterial ecology and resistance data, based on the latest peer-reviewed literature recommendations [24–26]. It was later replaced by high-dose intravenous amoxicillin-clavulanate. These molecules were effective against the pathogen identified, but 2 treatment failures occurred, requiring 3 revision surgeries.
Humans acquire
This therapeutic management resulted in resolution of the infection. The rarity and severity of this type of infection does not allow us to define recommendations or to hypothesize about specific early production of a biofilm. However, it seems necessary to consider all available means to reduce the bacterial inoculum and promote the effectiveness of antibiotics.
Conclusions
An exceptional early-onset spinal surgical site infection by
Figures
References:
1.. Chaudhary SB, Vives MJ, Basra SK, Reiter MF, Postoperative spinal wound infections and postprocedural diskitis: J Spinal Cord Med, 2007; 30(5); 441-51
2.. Rao SB, Vasquez G, Harrop J, Risk factors for surgical site infections following spinal fusion procedures: A case-control study: Clin Infect Dis, 2011; 53(7); 686-92
3.. Carbonnelle E, Pasteurella spp, SFM-microbiologie, 2019 https://www.sfm-micro-biologie.org/wp-content/uploads/2019/07/BACTERIE_Pasteurella.pdf
4.. Lodhi FAK, Shogren SL, Haque N: IDCases, 2020; 21; e00801
5.. Hubbert WT, Rosen MN: Am J Public Health Nations Health, 1970; 60(6); 1109-17
6.. Wilson BA, Ho M: Clin Microbiol Rev, 2013; 26(3); 631-55
7.. Lazennec JY, Fourniols E, Lenoir T, French Spine Surgery Society. Infections in the operated spine: Update on risk management and therapeutic strategies: Orthop Traumatol Surg Res, 2011; 97(6 Suppl.); S107-16
8.. Talan DA, Abrahamian FM, Moran GJ, Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to Emergency Departments: Clin Infect Dis, 2003; 37(11); 1481-89
9.. Massie JB, Heller JG, Abitbol JJ, Postoperative posterior spinal wound infections: Clin Orthop Relat Res, 1992(284); 99-108
10.. Levi AD, Dickman CA, Sonntag VK, Management of postoperative infections after spinal instrumentation: J Neurosurg, 1997; 86(6); 975-80
11.. Zeidman SM, Ducker TB, Raycroft J, Trends and complications in cervical spine surgery: 1989–1993: J Spinal Disord, 1997; 10(6); 523-26
12.. Cruse PJ, Foord R, A five-year prospective study of 23,649 surgical wounds: Arch Surg, 1973; 107(2); 206-10
13.. Wimmer C, Gluch H, Franzreb M, Ogon M, Predisposing factors for infection in spine surgery: A survey of 850 spinal procedures: J Spinal Disord, 1998; 11(2); 124-28
14.. Wille H, Dauchy FA, Desclaux A, Efficacy of debridement, antibiotic therapy and implant retention within three months during postoperative instrumented spine infections: Infect Dis (Lond), 2017; 49(4); 261-67
15.. Fernandez-Gerlinger MP, Arvieu R, Lebeaux D, Successful 6-week antibiotic treatment for early surgical-site infections in spinal surgery: Clin Infect Dis, 2019; 68(11); 1856-61
16.. Dubée V, Lenoir T, Leflon-Guibout V, Three-month antibiotic therapy for early-onset postoperative spinal implant infections: Clin Infect Dis, 2012; 55(11); 1481-87
17.. Kowalski TJ, Berbari EF, Huddleston PM, The management and outcome of spinal implant infections: Contemporary retrospective cohort study: Clin Infect Dis, 2007; 44(7); 913-20
18.. Collins I, Wilson-MacDonald J, Chami G, The diagnosis and management of infection following instrumented spinal fusion: Eur Spine J, 2008; 17(3); 445-50 [Erratum in: Eur Spine J. 2017;26(9):2478.
19.. Sierra-Hoffman M, Jinadatha C, Carpenter JL, Rahm M, Postoperative instrumented spine infections: A retrospective review: South Med J, 2010; 103(1); 25-30
20.. Maritati M, Liverani L, Gigante A: Cureus, 2023; 15(5); e38389
21.. Wei A, Dhaduk N, Taha B: IDCases, 2021; 26; e01277
22.. Honnorat E, Seng P, Savini H: BMC Infect Dis, 2016; 16(1); 435
23.. Zimmerli W, Trampuz A, Ochsner PE, Prosthetic-joint infections: N Engl J Med, 2004; 351(16); 1645-54
24.. Divi SN, Kepler CK, Boody BS, Consensus on implants in infections after spine surgery: Clin Spine Surg, 2020; 33(4); 163-71
25.. Conen A, Fux CA, Vajkoczy P, Trampuz A, Management of infections associated with neurosurgical implanted devices: Expert Rev Anti Infect Ther, 2017; 15(3); 241-55
26.. Prinz V, Vajkoczy P, Surgical revision strategies for postoperative spinal implant infections (PSII): J Spine Surg, 2020; 6(4); 777-84
Figures
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946165
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946414
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.944665
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946514
Most Viewed Current Articles
21 Jun 2024 : Case report
89,814
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
50,261
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,854
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,708
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030